Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350011 · ClinicalTrials.gov registry record · Phase 3
Tobacco Intervention in Buprenorphine Treatment
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 175
- Enrollment target
NCT01350011 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 175 participants.
The verdict
NCT01350011, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 175 participants
- Enrollment target
Study Summary
Drug addiction treatment patients, including those in treatment for opioid dependence, have a high rate of tobacco dependence, especially cigarette smoking. The proposed study evaluates an Innovative System (IS) for the treatment of tobacco dependence in one group of opioid treatment patients, those in buprenorphine maintenance. The specific aims of the study are to test the efficacy and the cost effectiveness of the IS. A secondary aim is obtain preliminary data about differences in use of non-nicotinic drugs between participants who achieve abstinence from cigarettes during the study, and those who do not.
Interventions
- BEHAVIORAL Innovative System
- BEHAVIORAL Standard Treatment Control (STC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2011-04-01 |
| Est. Completion | 2016-12-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01350011
The ClinicalTrials.gov registry entry for NCT01350011 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Innovative System is the first listed.
NCT01350011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01350011 about?
NCT01350011 is a clinical study titled "Tobacco Intervention in Buprenorphine Treatment". Drug addiction treatment patients, including those in treatment for opioid dependence, have a high rate of tobacco dependence, especially cigarette smoking. The proposed study evaluates an Innovative System (IS) for the treatment of tobacco dependence in one group of opioid treatment patients, those...
What is the current status of trial NCT01350011?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 175 participants. The study started on 2011-04-01. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT01350011?
The interventions under investigation include: Innovative System (BEHAVIORAL), Standard Treatment Control (STC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01350011?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.